#United States #Goldman Sachs #healthcare #Indianapolis #Eli Lilly

Eli Lilly's Participation in the Upcoming Goldman Sachs Global Healthcare Conference

Eli Lilly and Company, a leading name in the pharmaceutical industry, is set to take part in the highly anticipated Goldman Sachs 47th Annual Global Healthcare Conference scheduled for June 9, 2026. This event provides a platform for industry leaders to discuss the latest developments in healthcare and performance strategies.

Leadership Presentation

The company's Executive Vice President, Kenneth Custer, who also serves as the president of Lilly Cardiometabolic Health, will engage in a fireside chat during the conference at 3:20 p.m. Eastern Time. This interactive session will allow stakeholders and attendees to gain insights into Lilly's direction in cardiometabolic health, highlighting the latest research and innovations.

Access and Replay Information

Investors and interested parties can tune into a live audio webcast of the discussion, which will be accessible through the "Webcasts & Presentations" section of Lilly's investor relations website. For those unable to attend the live session, a replay of the conversation will be available on the same website for approximately 90 days, ensuring that vital information is accessible to those who wish to review it later.

About Eli Lilly

Eli Lilly has a rich legacy of over 150 years in the healthcare industry, focusing on turning scientific advancements into healing solutions for people around the globe. The company has been at the forefront of developing groundbreaking medicines that address diverse medical needs, particularly in areas like diabetes care, obesity, Alzheimer’s disease, and severe immune system disorders.

Their recent efforts are geared towards advancing new therapies through biotechnology and gene therapies, aimed at tackling some of the world’s most pressing health challenges. The company's commitment to innovation extends to making these treatments accessible and affordable, helping millions lead healthier lives.

Lilly’s strategic focus revolves around conducting clinical trials that not only reflect the diversity of global populations but also address significant healthcare disparities. By enhancing accessibility to medical solutions, Eli Lilly continues to build on its mission to improve the well-being of people worldwide.

As Lilly participates in this noteworthy conference, stakeholders will be eager to learn about upcoming products and therapeutic strategies that the company has in the pipeline. The discussions led by Kenneth Custer will provide clarity on Lilly’s approach to evolving healthcare needs and how the company plans to tackle the difficult challenges faced in the medical landscape today.

In conclusion, the Goldman Sachs Global Healthcare Conference is an excellent opportunity for Eli Lilly to showcase its pioneering work and commitment to improving health outcomes. By engaging directly with investors and industry partners, Lilly aims to reinforce its position as a leader in the pharmaceutical sector, promising innovative solutions for years to come.